High-dose inhaled flunisolide versus budesonide in the treatment of acute asthma exacerbations in preschool-age children

International Journal of Immunopathology and Pharmacology

Volumn 22, Issue 2, 2009, Pages 363-370

  Decimo, Fabio ^a   Maiello, N ^a   Del Giudice, M Miraglia ^a   Amelio, R ^a   Capristo, C ^a   Capristo, A F ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Asthma exacerbation; Budesonide; Flunisolide; FOT; Preschool children

Indexed keywords

BUDESONIDE; FLUNISOLIDE; HYDROCORTISONE; SALBUTAMOL;

ACUTE DISEASE; AIRWAY RESISTANCE; ARTICLE; ASTHMA; BREATHING MUSCLE; BRONCHODILATATION; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG MEGADOSE; DRUG USE; DYSPHONIA; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; MALE; METERED DOSE INHALER; MORNING DOSAGE; NEBULIZATION; OSCILLATION; PARALLEL DESIGN; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SLEEP DISORDER; THRUSH; WHEEZING;

EID: 67650501129     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200902200213     Document Type: Article

References (37)

1. American Lung Association Data and Statistic. Trend in asthma morbidity and mortality. New York: American Lung Association 2001.
2. Barbato A, Turato G, Baraldo S, et al. Epithelial damage and angiogenesis in the airways of children with asthma. Am J Respir Crit Care Med 2006; 174:975-981 (Pubitemid 44684445)
3. Saglani S, Payne DN, Zhu J, Wang Z, Nicholson AG, Bush A, Jeffery PK. Early detection of airway wall remodeling and eosinophilic inflammation in preschool wheezers. Am J Respir Crit Care Med 2007; 176:858-864 (Pubitemid 350097074)
4. Cane RS, Ranganathan SC, McKenzie SA. What do parents of wheezy children understand by "wheeze" ? Arch Dis Childhood 2000; 82:327-332
5. National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program. Guidelines for the Diagnosis and Management of Asthma. Full Report 2007. www.nhlbi.nih.gov/guidelines
6. British Guideline on the Management of Asthma. Thorax 2003; 58:1-92.
7. Global initiative for asthma (GINA). Global Strategy for Asthma Management and Prevention. Revised Nov. 2006.
8. Garrett J, Williams S, Wong C, Holdaway D. Treatment of acute asthmatic exacerbation with an increased dose of inhaled steroid. Arch Dis Childhood 1998; 79:12-17. (Pubitemid 28331246)
9. Rodrigo GJ. Rapid effects of inhaled corticosteroids in acute asthma: an evidence-based evaluation. Chest 2006; 130:1301-1311 (Pubitemid 44786720)
10. Volovitz B. Inhaled budesonide in the management of acute worsenings and exacerbations of asthma: a review of the evidence. Respir Med 2007; 101:685-95. (Pubitemid 46317243)
11. Gleeson JG, Price JF. Controlled trial of budesonide given by nebuhaler in preschool children with asthma. BMJ 1988; 297:163-166 (Pubitemid 18170580)
12. Wennergren G, Nordwall SL, Hedlin G, M ller C, Wille S, Asbrink Nilsson E. Nebulized budesonide for the treatment of moderate to severe asthma in infants and toddlers. Acta Paediatr 1996; 85:183-189
13. Nuhoglu Y, Atas E, Nuhoglu C, Iscan M, Ozcay S. Acute effect of nebulized budesonide in asthmatic children. J Investig Allergol Clin Immunol. 2005; 15:197-200. (Pubitemid 41546037)
14. De Benedictis FM, Miraglia Del Giudice M, Vetrella M, Tressanti F, Tronci A, Testi R, Dasic G: Flic12 Study Group. Nebulized fluticasone propionate vs. budesonide as adjunctive treatment in children with asthma exacerbation. J Asthma 2005; 42:331-336 (Pubitemid 41105703)
15. Nakanishi AK, Klasner AK, Rubin BK. A randomized controlled trial of inhaled flunisolide in the management of acute asthma in children. Chest 2003; 124:790-794 (Pubitemid 37123291)
16. Sekerel BE, Sackesen C, Tuncer A, Adalioglu G. The effect of nebulized budesonide treatment in children with mild to moderate exacerbations of asthma. Acta Paediatr 2005; 94:1372-1377 (Pubitemid 41510644)
17. Schuh S, Dick PT, Stephens D, Hartley M, Khaikin S, Rodrigues L, Coates AL. High-dose inhaled fluticasone does not replace oral prednisolone in children with mild to moderate acute asthma. Pediatrics 2006; 118:644-650 (Pubitemid 46085422)
18. Nielsen K, Bisgaard H. Discriminative capacity of bronchodilator response measured with three different lung function techniques in asthmatic and healthy children aged 2 to 5 years. Am J Respir Crit Care Med 2001; 164:554-559 (Pubitemid 32801655)
19. O'Callaghan C, White J, Jackson J, Barry PW, Kantar A. Delivery of nebulized budesonide is affected by nebulizer type and breathing pattern. J Pharm Pharmacol. 2005; 57:787-790 (Pubitemid 40694888)
20. O'Callaghan C, White J, Jackson J, Barry P, Kantar A. The output of flunisolide from different nebulisers. J Pharm Pharmacol 2002; 54:565-569
21. Y ksel H, Berardino L, Y ksel D, Yilmaz O, Burak Z. Improved efficacy of aerosol delivery to distal airways in pediatric subjects using a new spacer mouth-mask. Allerg Immunol (Paris) 2007; 39:64-68
22. Oostveen E, MacLeod D, Lorino H, Farre R, Hantos Z, Desager K, Marchal F. ERS Task Force on Respiratory Impedance Measurements. The forced oscillation technique in clinical practice: methodology, recommendations and future developments. Eur Respir J 2003; 22:1026-1041
23. Progetto Mondiale Asma: GINA Linee guida italiane Aggiornamento 2007. www.ginasma.it
24. Kelly HW. Pharmaceutical characteristics that influence the clinical efficacy of inhaled corticosteroids. Ann Allergy Asthma Immunol 2003; 91:326-334 (Pubitemid 37266335)
25. Volovitz B, Soferman R, Blau H, Nussinovitch M, Varsano I. Rapid induction of clinical response with short-term high-dose starting schedule of budesonide nebulizing suspension in young children with recurrent wheezing episodes. J All Clin Immunol 1998; 101:464-469 (Pubitemid 28208249)
26. Sano F, Cortez GK, Sol D, Naspitz CK. Inhaled budesonide for the treatment of acute wheezing and dyspnea in children up to 24 months old receiving intravenous hydrocortisone. J Allergy Clin Immunol 2000; 105:699-703. (Pubitemid 30226442)
27. Devidayal , Singhi S, Kumar L, Jayshree M. Efficacy of nebulized budesonide compared to oral prednisolone in acute bronchial asthma. Acta Paediatr 1999; 88:835-840 (Pubitemid 29439604)
28. Rodrigo G, Rodrigo C. Inhaled flunisolide for acute severe asthma. Am J Respir Crit Care Med 1998; 157:698-703. (Pubitemid 28150675)
29. Kantar A, Mroueh S, Fiocchi A. A reappraisal of the clinical safety of nebulized flunisolide in pediatric asthma: The Italian experience. Allergy Asthma Proc 2007; 28:1-17.
30. Rohatagi S, Appajosyula S, Derendorf H, Szefler S, Nave R, Zech K, Banerji D. Risk-benefit value of inhaled glucocorticoids: A pharmacokinetic/ pharmacodynamic perspective. J Clin Pharmacol 2004; 44:37-47. (Pubitemid 38005092)
31. Winkler J, Hochhaus G, Derendorf H. How the lung handles drugs: pharmacokinetics and pharmacodynamics of inhaled corticosteroids. Proc Am Thorac Soc 2004; 1:356-363
32. Johnson m. Pharmacodinamics and pharmacokinetics of inhaled glucocorticoids. J Allergy Clin Immunol 1996; 97:169-176 (Pubitemid 26049498)
33. Hauber HP, Gotfried M, Newman K, Danda R, Servi RJ, Christodoulopoulos P, Hamid Q. Effect of HFA-flunisolide on peripheral lung inflammation in asthma. J Allergy Clin Immunol 2003; 112:58-63. (Pubitemid 36819807)
34. Lipworth BJ. Therapeutic implications of non-genomic glucocorticoid activity. Lancet 2000; 356:87-89 (Pubitemid 30438503)
35. Wanner A, Horvath G, Brieva JL, Kumar SD, Mendes ES. Non-genomic actions of glucocorticosteroids on the airway vasculature in asthma. Proc Am Thorac Soc 2004; 1:235-238
36. Marotta A, Klinnert MD, Price MR, Larsen GL, Liu AH. Impulse oscillometry provides an effective measure of lung dysfunction in 4-year-old children at risk for persistent asthma. J Allergy Clin Immunol 2003; 112:317-322 (Pubitemid 36981371)
37. Delacourt O, Lorino H, Herve-Guillot M, Reinert P, Harf A, Housset B. Use of the forced oscillation technique to assess airway obstruction and reversibility in children. Am J Respir Crit Care Med 2000; 161:730-736 (Pubitemid 30171724)